Shattuck Labs announces Phase 2 trial and executive appointment
Shattuck Labs said it will start a Phase 2 clinical trial of SL-325 in hidradenitis suppurativa and appointed Shoba Ravichandran, M.D., as senior vice president of clinical development.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.